FR-31564 (Fosmidomycin, Sodium Salt)
FR-31564 (Fosmidomycin, Sodium Salt)
Invitrogen™

FR-31564 (Fosmidomycin, Sodium Salt)

The phosphonate antibiotic FR-31564 (fosmidomycin) is an effective antimalarial agent that functions by blocking a mevalonate-independent pathway of isoprene synthesis.자세히 알아보기
Have Questions?
카탈로그 번호수량
F2310325 mg
카탈로그 번호 F23103
제품 가격(KRW)
447,000
Online offer
Ends: 31-Dec-2025
525,000
할인액 78,000 (15%)
Each
카트에 추가하기
수량:
25 mg
제품 가격(KRW)
447,000
Online offer
Ends: 31-Dec-2025
525,000
할인액 78,000 (15%)
Each
카트에 추가하기
The phosphonate antibiotic FR-31564 (fosmidomycin) is an effective antimalarial agent that functions by blocking a mevalonate-independent pathway of isoprene synthesis. The antibiotic activity of FR-31564 is potentiated by glucose 1-phosphate. FR-31564 is also active against a variety of gram-negative bacteria.
For Research Use Only. Not for use in diagnostic procedures.
사양
분자식C4H9NNaO5P
수량25 mg
권장 스토리지Store in freezer (-5°C to -30°C) and protect from light.
배송 조건Room Temperature
물리적 형태Powder
제품 유형Antibiotic
Unit SizeEach

자주 묻는 질문(FAQ)

How can I decontaminate my cultures?

When an irreplaceable culture becomes contaminated, researchers may attempt to eliminate or control the contamination.

1. Determine if the contamination is bacteria, fungus, mycoplasma, or yeast. Read more here to view characteristics of each contaminant.
2. Isolate the contaminated culture from other cell lines.
3. Clean incubators and laminar flow hoods with a laboratory disinfectant, and check HEPA filters.
4. Antibiotics and antimycotics at high concentrations can be toxic to some cell lines. Therefore, perform a dose-response test to determine the level at which an antibiotic or antimycotic becomes toxic. This is particularly important when using an antimycotic such as Gibco Fungizone reagent or an antibiotic such as tylosin.

The following is a suggested procedure for determining toxicity levels and decontaminating cultures:

1. Dissociate, count, and dilute the cells in antibiotic-free media. Dilute the cells to the concentration used for regular cell passage.
2. Dispense the cell suspension into a multiwell culture plate or several small flasks. Add the antibiotic of choice to each well in a range of concentrations. For example, we suggest the following concentrations for Gibco Fungizone reagent: 0.25, 0.50, 1.0, 2.0, 4.0, and 8.0 µg/mL.
3. Observe the cells daily for signs of toxicity such as sloughing, appearance of vacuoles, decrease in confluency, and rounding.
4. When the toxic antibiotic level has been determined, culture the cells for two to three passages using the antibiotic at a concentration one- to two-fold lower than the toxic concentration.
5. Culture the cells for one passage in antibiotic-free media.
6. Repeat step 4.
7. Culture the cells in antibiotic-free medium for four to six passages to determine if the contamination has been eliminated.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

What antibiotics do you offer to help control or eliminate cell culture contamination?

Please view the following page to browse the cell culture antibiotics we offer (https://www.thermofisher.com/us/en/home/life-science/cell-culture/mammalian-cell-culture/antibiotics.html).

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

인용 및 참조 문헌 (50)

인용 및 참조 문헌
Abstract
In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.
Authors:Wiesner J, Henschker D, Hutchinson DB, Beck E, Jomaa H
Journal:Antimicrob Agents Chemother
PubMed ID:12183243
'Fosmidomycin acts through inhibition of 1-deoxy-D-xylulose 5-phosphate (DOXP) reductoisomerase, a key enzyme of the nonmevalonate pathway of isoprenoid biosynthesis. It possesses potent antimalarial activity in vitro and in murine malaria. In a recent clinical study, fosmidomycin was effective and well tolerated in the treatment of patients with acute uncomplicated Plasmodium ... More
Isolation of the dxr gene of Zymomonas mobilis and characterization of the 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Authors:Grolle S, Bringer-Meyer S, Sahm H
Journal:FEMS Microbiol Lett
PubMed ID:11004410
'The gene encoding the second enzyme of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway for isopentenyl diphosphate biosynthesis, 1-deoxy-D-xylulose 5-phosphate (DXP) reductoisomerase, was cloned and sequenced from Zymomonas mobilis. The deduced amino acid sequence showed the highest identity (48.2%) to the DXP reductoisomerase of Escherichia coli. Biochemical characterization of the purified DXP ... More
Structural basis of fosmidomycin action revealed by the complex with 2-C-methyl-D-erythritol 4-phosphate synthase (IspC). Implications for the catalytic mechanism and anti-malaria drug development.
Authors:Steinbacher S, Kaiser J, Eisenreich W, Huber R, Bacher A, Rohdich F
Journal:J Biol Chem
PubMed ID:12621040
'2-C-Methyl-d-erythritol 4-phosphate synthase (IspC) is the first enzyme committed to isoprenoid biosynthesis in the methylerythritol phosphate pathway, which represents an alternative route to the classical mevalonate pathway. As it is present in many pathogens and plants, but not in man, this pathway has attracted considerable interest as a target for ... More
In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
Authors:Neu HC, Kamimura T
Journal:Antimicrob Agents Chemother
PubMed ID:7271270
'The in vitro and in vivo activity of FR-31564 [sodium hydrogen 3-(N-hydroxyformamido)propylphosphate] against gram-positive and -negative aerobic and anaerobic bacteria was investigated and compared with that of fosfomycin, cephalexin, carbenicillin, and trimethoprim-sulfamethoxazole. The in vitro activity of FR-31564 was markedly enhanced when combined with glucose 6-phosphate or fructose 6-phosphate, but ... More
Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis.
Authors:Figueredo VM, Neu HC
Journal:J Antimicrob Chemother
PubMed ID:3139615
'Pseudomonas aeruginosa remains the most common respiratory pathogen causing morbidity and mortality in cystic fibrosis (CF) patients. The in-vitro activity of ciprofloxacin and fosfomycin (calcium and tromethamine salts) in combination against P. aeruginosa isolates from CF patients, all of whom had received previous courses of ciprofloxacin, was evaluated by agar ... More